Danish microRNA consortium receives grant for new diagnostics  

2006.01.24
A Danish consortium has been granted DKK 10 m from the Council for Technology and Innovation to develop a new diagnostic technology for measuring microRNA

A Danish consortium has been granted DKK 10 m (USD 1.6 m) from the Council for Technology and Innovation, part of the Danish Ministry of Science, Technology and Innovation, to develop a new diagnostic technology for measuring microRNA. The consortium comprises the University of Copenhagen, Århus University Hospital, Bioneer, Exiqon, Visiopharm and Novo Nordisk.

MicroRNA molecules are central in basic control systems in living cells and are thought to determine whether cells develop correctly or become diseased. MicroRNA molecules constitute a type of hitherto unknown markers which are expected to be important for the development of rapid and reliable diagnostics for a number of major diseases.

Poul Anderson, managing director of Bioneer and coordinator of the project says in a press release that the consortium is based on a strong and visible international position in microRNA which the Danish company Exiqon has established, and that the participants in the project gain access to frontline technology with the opportunity to create a strong Danish platform in microRNA diagnostics.

The consortium is investing DKK 22 m (USD 3.5 m) in the project, bringing the total to DKK 32 m (USD 5.1 m) for a three year period. The news was reported by BiotechDenmark.

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×